Moleculin Biotech's IPO

Moleculin Biotech raised a round of funding on June 02, 2016. Investors include Public.

Moleculin Biotech is a preclinical and clinical-stage pharmaceutical company focused on the development of anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Can…

Articles about Moleculin Biotech's IPO: